← FDA DRUG APPROVALS

FDA ANDA · ANDA072795

METAPROTERENOL SULFATE

Sponsor: WATSON LABS

APPLICATION
ANDA072795
TYPE
ANDA
ORIGINAL APPROVAL
1991-01-31
LATEST ACTION
1992-10-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METAPROTERENOL SULFATEDiscontinued
METAPROTERENOL SULFATE 20MG · TABLET · ORAL

Approval history

1992-10-16Manufacturing (CMC) · Supplement 1AP
1992-10-09Labeling · Supplement 2AP
1991-01-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →